← Leaderboards
Guy Hobbs
Medical University Of South Carolina
$1,461,637
Attributed
$1,461,637
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $806.1K · FY2021–24$1M$750K$500K$250K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$1,461,637 · 2
By mechanism
P20$1,461,637 · 2
Top collaborators
No co-investigators on record.
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Stephen A Duncan$28,157,111
- Don C Rockey$16,593,570
- John P O'Bryan$5,496,943
- John J Lemasters$27,282,033
- Besim Ogretmen$19,638,711
Others in their field
Other Emerging Leaders on “Therapeutically Effective”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$84,871,609
- Beth Baseler · Leidos Biomedical Research, Inc.$71,972,108
- Susan M Landau · University Of California Berkeley$47,252,026
Research focus
Therapeutically EffectiveBiological ModelsBiotinCancer ModelCell ModelCellsCenters Of Research ExcellenceDigestive System DisordersEnvironmentGenomic LocusKras2 GeneKrasg12dLigationLiver DiseasesMalignant Neoplasm Of PancreasMapsMouse ModelMutantMutationNeoplasticOncogenicOrganoidsPancreasPancreatic Ductal Adenocarcinoma
Grant awards (4)
Defining the KRAS mutation specific interactions in pancreas cancer$224,250
P20 · FY2024 · GM · contact PI
Defining the KRAS mutation specific interactions in pancreas cancer$806,129
P20 · FY2023 · GM · contact PI
Defining the KRAS mutation specific interactions in pancreas cancer$206,129
P20 · FY2022 · GM · contact PI
Defining the KRAS mutation specific interactions in pancreas cancer$225,129
P20 · FY2021 · GM · contact PI